[EN] SUBSTITUTED DIHYDROPYRAZINEDIONES AS MODULATORS OF THE NMDA RECEPTOR [FR] DIHYDROPYRAZINEDIONES SUBSTITUÉES EN TANT QUE MODULATEURS DU RÉCEPTEUR NMDA
[EN] SUBSTITUTED DIHYDROPYRAZINEDIONES AS MODULATORS OF THE NMDA RECEPTOR<br/>[FR] DIHYDROPYRAZINEDIONES SUBSTITUÉES EN TANT QUE MODULATEURS DU RÉCEPTEUR NMDA
申请人:SCHROEDINGER INC
公开号:WO2022015624A1
公开(公告)日:2022-01-20
This present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (I) and pharmaceutically acceptable salts thereof and methods of using the compounds and compositions for treating neurological disorders such as schizophrenia, mild cognitive impairment and chronic neuropathic pain.